Stephen J. Meltzer

Stephen J. Meltzer

Gastroenterology

1800 Orleans Street
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Retraction Notice to: "Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma" Gastroenterology 2018;154:2137-2151.e1.

Retraction Notice to: "Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma" Gastroenterology 2018;154:2137-2151.e1.

Journal: Gastroenterology

Published: September 03, 2026

A machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma.

A machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma.

Journal: Gut microbes

Published: December 24, 2025

Increasing age, neural invasion, extramural vascular invasion, and short-course radiotherapy in locally advanced rectal cancer are associated with decreased tumor regression: a retrospective cohort study.

Increasing age, neural invasion, extramural vascular invasion, and short-course radiotherapy in locally advanced rectal cancer are associated with decreased tumor regression: a retrospective cohort study.

Journal: Techniques in coloproctology

Published: April 02, 2025

Delivery of cancer cell-derived extracellular vesicles modulates the morphology and gene expression of Barrett esophagus and duodenal organoids (Article).

Delivery of cancer cell-derived extracellular vesicles modulates the morphology and gene expression of Barrett esophagus and duodenal organoids (Article).

Journal: Biochemical and biophysical research communications

Published: January 24, 2025

Chromosome 20q gene signature associated with colorectal cancer progression.

Chromosome 20q gene signature associated with colorectal cancer progression.

Journal: Oncology reports

Published: December 30, 2024

Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.

Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.

Journal: The American journal of gastroenterology

Published: August 16, 2024

Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.

Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.

Journal: The American journal of gastroenterology

Published: August 13, 2024

Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study.

Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study.

Journal: Gut

Published: July 15, 2024

Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

Journal: Diagnostics (Basel, Switzerland)

Published: July 11, 2024

Neoplastic Progression Risk in Females With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data.

Neoplastic Progression Risk in Females With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 02, 2024

Cancer Methylation Biomarker Detection in an Automated, Portable, Multichannel Magnetofluidic Platform.

Cancer Methylation Biomarker Detection in an Automated, Portable, Multichannel Magnetofluidic Platform.

Journal: ACS nano

Published: April 26, 2024

Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus.

Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus.

Journal: The American journal of gastroenterology

Published: December 14, 2023

Showing 1-12 of 97

Last Updated: 09/26/2026